Isomorphic Labs, the AI drug-discovery startup founded by former Google DeepMind chief Demis Hassabis, said on Tuesday it raised $5 billion in Series C funding, three and a half months after Hassabis stepped back as DeepMind CEO. Greenoaks and Sequoia co-led the round, with Andreessen Horowitz and A